Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
MS
SERVE-HF: Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
1 other identifier
interventional
312
8 countries
94
Brief Summary
The purpose of this study is to assess changes in left ventricular performance using echocardiography as well as ventricular remodelling, changes in sleep and changes in mood, anxiety and cognitive functions occurring as a result of treatment of predominant central sleep apnoea by adaptive servoventilation (ASV) in chronic heart failure in addition to optimal medical therapy in chronic heart failure. This will be a substudy of the SERVE-HF study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4 heart-failure
Started Aug 2012
Typical duration for phase_4 heart-failure
94 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2010
CompletedFirst Posted
Study publicly available on registry
July 16, 2010
CompletedStudy Start
First participant enrolled
August 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedAugust 7, 2015
August 1, 2015
2.7 years
July 15, 2010
August 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Left Ventricular Ejection Fraction (LVEF) from baseline to 12 months of therapy as measured by echocardiography (Echo).
Baseline (Randomization), 6- and 12 month-Follow-up-visit
Secondary Outcomes (10)
Changes in left and right ventricular function
Baseline (Randomization), 6-and 12-month-Follow-up visit
Changes in LV systolic and diastolic indexed volumes
Baseline (Randomization), 6- and 12-month-Follow-up-visit
Changes in right ventricular (RV) systolic and diastolic indexed volumes
Baseline (Randomization), 6- and 12-month-Follow-up-visit
Changes in LV and RV mass
Baseline (Randomization), 6- and 12-month-Follow-up-visit
Changes in LV sphericity index and LV end-systolic global wall stress
Baseline (Randomization), 6- and 12-month-Follow-up-visit
- +5 more secondary outcomes
Study Arms (2)
Therapy with adaptive servo ventilation
ACTIVE COMPARATORoptimal medical therapy + adaptive servoventilation
Optimal medical therapy according to guidelines
NO INTERVENTIONoptimal medical therapy
Interventions
Patients randomised to therapygroup should use the adaptive servoventilation (ASV) device each night at least 3 hours
Eligibility Criteria
You may not qualify if:
- Over 22 years of age
- Severe Chronic Heart Failure (CHF) with NYHA class III-IV or NYHA class II with at least one hospitalisation for HF within the last 24 months
- Left ventricular ejection fraction (LVEF) less than or equal to 45% by means of echocardiography, radionucleotide angiography, left ventriculography or cardiac MRI documented less than 12 weeks before randomisation
- Diagnosis of sleep disordered breathing (SDB) with an apnoea-hypopnoea-index (AHI) of \>15/hr with at least 50% central events and a central AHI of at least 10/hr
- Clinically stable with no change in medication and no unplanned hospitalisation for heart failure in preceding month
- Optimised medical treatment according to the applicable guidelines
- Able to provide informed consent
- Predominant central sleep apnoea (apnoea hypopnoea index \> 15/hour with ≥ 50% central events and a central AHI ≥10/hour, derived from full polysomnography (based on total sleep time), documented less than 4 weeks before randomization. Flow measurements have to be performed with nasal cannula
- Significant chronic obstructive pulmonary disease (COPD) with Forced Expiratory Volume within one second (FEV1)\<50% predicted
- Current use of Positive Airway Pressure (PAP) therapy
- Life expectancy \< 1 year for diseases unrelated to chronic heart failure
- Cardiac surgery, Percutaneous coronary intervention (PCI), Myocardial Infarction (MI) or unstable angina within 6 months prior to randomisation
- Implantation of ICD (implanted cardiodefibrillator) or CRT (cardiac resynchronisation therapy) scheduled or within 6 months prior to randomisation
- Transient ischemic attack (TIA) or Stroke within 3 months prior to randomisation
- Primary hemodynamically significant uncorrected valvular heart disease, obstructive or regurgitant, or any valvular disease expected to lead to surgery during the trial
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ResMedlead
Study Sites (94)
Westmead Hospital
Westmead, New South Wales, 2145, Australia
Rivercity Private Hospital
Auchenflower, Queensland, 4066, Australia
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
Melbourne Sleep Disorders Centre
East Melbourne, Victoria, 3002, Australia
St. Vincents and Mercy Private Hospital
Melbourne, Victoria, 3065, Australia
Hollywood Private Hospital (CVS)
Nedlands, Western Australia, 6009, Australia
St. Anne's University Hospital
Brno, 65691, Czechia
Helsinki University Hospital
Helsinki, 00290, Finland
Unesta Research Centre
Tampere, 33520, Finland
Tampere University Hospital, Pirkanmaa sairaanhoitopiiri
Tampere, 33521, Finland
Clinique Mutualiste des Eaux Claires
Grenoble, 38000, France
CHU Grenoble, Hopital Michallon
Grenoble, 38043, France
CHU de Poitiers
Poitiers, 86000, France
Universitätsklinikum Aachen
Aachen, 52074, Germany
DRK Krankenhaus
Alzey, 55232, Germany
Herzzentrum Bad Krozingen
Bad Krozingen, 79189, Germany
Herz- und Diabeteszentrum NRW
Bad Oeynhausen, 32545, Germany
Charité Campus Mitte CCM
Berlin, 10117, Germany
Charité Campus Mitte
Berlin, 10117, Germany
POLIKUM Friedenau
Berlin, 12157, Germany
Unfallkrankenhaus Berlin
Berlin, 12683, Germany
Jüdisches Krankenhaus Berlin
Berlin, 13347, Germany
Praxis für Lunge Herz und Schlaf
Bielefeld, 33617, Germany
Kardiologische Praxis Marschner
Bonn, 53225, Germany
Helios Klinikum Borna
Borna, 04552, Germany
Kardiologie Brühl
Brühl, 50321, Germany
Gemeinschaftspraxis Kardiologie Dr. Becker
Castrop-Rauxel, 44575, Germany
Kardiologische Praxis Dr. Isbruch
Castrop-Rauxel, 44577, Germany
Malteser Krankenhaus St. Hildegardis
Cologne, 50931, Germany
Klinikum der Universität zu Köln- Herzzentrum
Cologne, 50937, Germany
Klinikum der Universität zu Köln-Schlaflabor
Cologne, 50937, Germany
Praxis Dr. Anselm Bäumer
Cologne, 51065, Germany
Gemeinschaftspraxis Dres. Gysan/Heinzler/May
Cologne, 51105, Germany
Praxis Dr. Hecker
Dortmund, 44135, Germany
Kardiologische Praxis Dr. Wetzel
Dortmund, 44141, Germany
Praxis Dr. Lodde
Dortmund, 44147, Germany
Facharztzentrum Dresden-Neustadt GbR
Dresden, 01099, Germany
Gemeinschaftpraxis Dres. Schmidt/Gronke
Dresden, 01219, Germany
Praxis Dr. Hohensee
Dresden, 01277, Germany
Herzzentrum Universität Dresden
Dresden, 01307, Germany
Khs Florence-Nightingale
Düsseldorf, 40489, Germany
Kardiologie Oberkassel
Düsseldorf, 40545, Germany
Gemeinschaftspraxis PD Dr. Lankisch
Düsseldorf, 40597, Germany
Universitätsklinikum Essen
Essen, 45122, Germany
Kardiologie Praxis Dr. Bonnekamp
Essen, 45136, Germany
Praxis Dr. Tekiyeh
Essen, 45136, Germany
Ruhrlandklinik Essen
Essen, 45239, Germany
Kath. Kliniken Essen/ Philippusstift
Essen, 45359, Germany
Gemeinschaftspraxis Dres. Guckenbiehl
Flonheim, 55237, Germany
CardioVaskuläres Centrum Frankfurt
Frankfurt, 60389, Germany
Praxis Dr. Diedrichs
Frechen, 50226, Germany
Universitätsklinikum Freiburg
Freiburg im Breisgau, 79106, Germany
Kardiologische Praxis Gütersloh
Gütersloh, 33330, Germany
Gemeinschaftspraxis Dres Leischik/Littwitz
Hagen, 58095, Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, 20246, Germany
Asklepios Klinik Barmbek
Hamburg, 22291, Germany
Universitätsklinikum Heidelberg
Heidelberg, 69120, Germany
Thoraxklinik Heidelberg gGmbH
Heidelberg, 69126, Germany
Lungenklinik Hemer
Hemer, 58675, Germany
B&B GmbH
Herne, 44623, Germany
Cardio-Praxis Herne Dr. Furche
Herne, 44623, Germany
Gemeinschaftspraxis Dr. Bruch
Herne, 44629, Germany
Kardiologische Praxis Dr. Schlichting
Herne, 44649, Germany
Augusta-Kranken-Anstalt gGmbH Thoraxzentrum Ruhrgebiet
Herne, 44651, Germany
St. Elisabeth-Hospital Herten gGmbH
Herten, 45699, Germany
Lungenfachklinik Immenhausen
Immenhausen, 34376, Germany
Cardiopraxis Ingelheim
Ingelheim, 55218, Germany
Gemeinschaftspraxis Dres. Dobler/Turin
Karlstadt am Main, 97753, Germany
Universität Leipzig -Herzzentrum
Leipzig, 04289, Germany
Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie
Lübeck, 23538, Germany
Universitätsklinikum Schleswig-Holstein Campus Lübeck-Schlaflabor
Lübeck, 23538, Germany
Praxis für Kardiologie Dr. med. Menz
Menden, 58706, Germany
Krankenhaus Bethanien
Moers, 47441, Germany
Kardiologische Praxis Dr. Schön
Mühldorf, 84453, Germany
Evangelisches Krankenhaus Mülheim
Mülheim, 45468, Germany
Lungenärzte am Rotkreuzplatz
München, 80634, Germany
Klinikum Augustinum München
München, 81375, Germany
Universitätsklinikum Münster
Münster, 48149, Germany
Städtisches Khs Lukas
Neuss, 41472, Germany
Kardiologische Praxis Nienburg
Nienburg, 31582, Germany
Praxis Dr. Fröhlich
Ratingen, 40885, Germany
Universitätsklinikum Regensburg
Regensburg, 93053, Germany
Khs St. Adolf Stift
Reinbek, 21465, Germany
Praxis Dr. Hein
Reinbek, 21465, Germany
Katharinen Hospital Unna
Unna, 59423, Germany
Praxis Dr. Gerritsen
Waldkraiburg, 84478, Germany
Kardiologisch angiologische Gemeinschaftspraxis
Wiesbaden, 65183, Germany
Kardiologische Gemeinschaftspraxis Dr. K. Vorbeck
Wiesbaden, 65183, Germany
Missionsärztliche Klinik Würzburg
Würzburg, 97074, Germany
Comprehensive Heart Failure Center, Universitätsklinikum Würzburg
Würzburg, 97080, Germany
University Medical Center Groningen
Groningen, 9700 RB, Netherlands
Cardiocentro Ticino
Lugano, 6900, Switzerland
Ospedale Regionale di Lugano
Lugano, 6903, Switzerland
Brompton Hospital
London, London, UK-SW36NP, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Cowie, Prof
Royal Brompton Hospital, London
- STUDY DIRECTOR
Holger Woehrle, MD
ResMed
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2010
First Posted
July 16, 2010
Study Start
August 1, 2012
Primary Completion
April 1, 2015
Study Completion
June 1, 2015
Last Updated
August 7, 2015
Record last verified: 2015-08